Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

The Independent UK

‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Young-onset Alzheimer’s can be diagnosed from as early as 30 – and the symptoms are often different

Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanders: Alzheimer's drug too expensive

"The high price of Leqembi threaten Medicare's finances, it will also negatively impact seniors on fixed incomes"

Salon

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

The Independent UK

Fiona Phillips ‘hugely touched’ by support after revealing Alzheimer’s diagnosis

The former GMTV anchor announced she was diagnosed more than a year ago with the condition

Evening Standard

Is Alzheimer's disease hereditary? What are your chances of getting Alzheimer's disease if your parents had it

There are certain gene changes that can increase your likelihood of getting the disease

Wales Online

Read news from The Economist, FT, and more,
with one subscription

What are the symptoms of Alzheimer’s? New medication donanemab found to slow mental decline

Scientists believe that Alzheimer’s is triggered because of an abnormal build-up of proteins in the brain

Evening Standard

Early signs of Alzheimer's and when to see a GP as Fiona Phillips diagnosed

The TV presenter has gone public about her diagnosis

Wales Online

The form of exercise that can help prevent Alzheimer’s disease, according to new study

Experiments with genetically modified mice reveal form of exercise that can help prevent condition

The Independent UK

Exercising Regularly May Help Prevent Alzheimer’s

Regular gym work-outs could stave off Alzheimer's, say scientists

Zenger

Higher levels of lean muscle might protect against Alzheimer’s disease – study

Further research is needed to investigate the clinical and public health implications of the findings.

The Independent UK

Extra benefits of intermittent fasting

"Intermittent fasting has been shown to have various health benefits [including] the promotion of brain health"

Salon

Intermittent fasting could help protect the brain from age-related diseases like Alzheimer's

As the world population has grown older, Alzheimer’s disease has become increasingly common. Alzheimer’s disease is the most prevalent form of dementia. Dementia is a term used to describe a range of symptoms linked to the decline in brain function with age. Symptoms include memory loss, communication difficulties, problem-solving struggles,…

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Own as Alzheimer's Drugs Bring Relief

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

Fortune

Are you at risk of developing Alzheimer's Disease? A simple screener can tell—and so can these 11 early warning signs

A quick test that mimics real-life phone tasks can tell if a senior is at risk for Alzheimer’s disease, according to a new study.

The Independent UK

LOCALIZE IT: From birth to death, Black Americans struggle with health care system

EDITORS/NEWS DIRECTORS:

Wales Online

All you need to know about weight-loss drug Wegovy and Ozempic tipped to treat dementia

Although age is by far the greatest risk factor for dementia, obesity and type 2 diabetes are also major risk factors

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Wegovy and Ozempic: could the new weight-loss drug also treat dementia?

Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.

Wales Online

Scientists make Alzheimer's breakthrough thanks to man who could hold cure in his genes

Rare genetic resilience to the disease has been identified in a second patient

Inverse

Scientists Discover New Genetic Variants That Protect Against Alzheimer’s Disease

In a new study, researchers identified a rare gene mutation that may offer resiliency against Alzheimer's disease.

The Independent UK

Researchers identify rare genetic resilience to Alzheimer’s disease – study

Researchers suggest the findings could open a door for the prevention and treatment of incurable diseases.

Dynamite News

Study reveals traffic-related air pollution affects brain function

According to a study from the University of California, Irvine, exposure to traffic-related air pollution causes memory loss, cognitive decline, and the activation of brain pathways linked to the onset of Alzheimer's disease. Read further on Dynamite News:

Wales Online

All you need to know about 'promising' new Alzheimer's drug

Donanemab was shown in a late-stage trial to slow cognitive decline more than a third

The Conversation

New Alzheimer’s drug: what you need to know about donanemab’s promising trial results

American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35%. While these results do sound promising, the full data…

1 … 7 8 9 10

People

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Alzheimer Research UK

Massachusetts General Hospital

48 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.